It is interesting that a novel drug HM90822B showed cell growth-inhibitory effect on NSCLC cells, especially on IAP and EGFR-overexpressing cells, because both molecules are regarded as oncogenic and tumorigenic in different types of cancers. Here, EGFR is linked to cancer.